APA (7th ed.) Citation

Santamaria, M., Neth, O., Douglass, J. A., Krivan, G., Kobbe, R., Bernatowska, E., . . . Lin, J. (2022). A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency. Journal of clinical immunology, 42(3), 500-511. https://doi.org/10.1007/s10875-021-01181-6

Chicago Style (17th ed.) Citation

Santamaria, Manuel, et al. "A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency." Journal of Clinical Immunology 42, no. 3 (2022): 500-511. https://doi.org/10.1007/s10875-021-01181-6.

MLA (9th ed.) Citation

Santamaria, Manuel, et al. "A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency." Journal of Clinical Immunology, vol. 42, no. 3, 2022, pp. 500-511, https://doi.org/10.1007/s10875-021-01181-6.